Blood routine test in mild and common 2019 coronavirus (COVID-19) patients

The new 2019 coronavirus disease (COVID-19), according to the World Health Organization (WHO), has been characterized as a pandemic. As more is being discovered about this virus, we aim to report findings of the complete blood count (CBC) of COVID-19 patients. This would serve in providing physician...

Descripción completa

Detalles Bibliográficos
Autores principales: Djakpo, Dodji Kossi, Wang, Zhiquan, Zhang, Rong, Chen, Xin, Chen, Peng, Antoine, Malyn Martha Lilac Ketisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Respiratory System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414516/
https://www.ncbi.nlm.nih.gov/pubmed/32725148
http://dx.doi.org/10.1042/BSR20200817
Descripción
Sumario:The new 2019 coronavirus disease (COVID-19), according to the World Health Organization (WHO), has been characterized as a pandemic. As more is being discovered about this virus, we aim to report findings of the complete blood count (CBC) of COVID-19 patients. This would serve in providing physicians with important knowledge on the changes that can be expected from the CBC of mild and normal COVID-19 patients. A total of 208 mild and common patients were admitted at the Dongnan Hospital located in the city of Xiaogan, Hubei, China. The CBCs of these patients, following a confirmed diagnosis of COVID-19, were retrospectively analyzed and a significant P<0.05 was found after a full statistical analysis was conducted using the Statistical Package for the Social Sciences (IBM SPSS). CBC analysis revealed changes in the levels of red blood cells (RBCs), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and C-reactive protein (CRP). Clinicians should expect similar findings when dealing with the new COVID-19.

Ejemplares similares